<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c57/4905446/83ae4e71cda6/oncotarget-07-10879-g001.jpg"/> </div> <div class="text-side"> <h1>Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients.</h1> <p>Higher expression of AN32A in OSCC patientsANP32A expression was detected in oral cancer patients and in non-tumor tissues by performing immunohistochemistry. a. ANP32A expression in the non-tumor areas of oral mucosa. b.-d. Different staining intensities of ANP32A in OSCC tissues. The scoring criteria for ANP32A immunoreactivity are described in the Materials and methods section. The cellular staining was classified using a scale of (±, 1+, 2+) as follows: ± weak staining b., 1+ moderate staining c., 2+ strong staining d..e. &amp; f. Endometrial and breast cancer was used as a positive and negative control respectively. Representative images show the consistent expression of ANP32A. Left panel: magnification×100. Right panel: magnification ×400.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/26918356/" target="_blank">26918356</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>